Abstract:Background Colorectal cancer (CRC) is one of the most prevalent gastrointestinal cancers. Evidence for the importance of inflammation and immunology in the development and progression of CRC is growing steadily. The purpose of this study was to determine the clinical importance of Lactic Dehydrogenase (LDH) to Albumin (ALB) Ratio (LAR) and immune-inflammation biomarkers (IIBs) in patients with CRC. Methods This study enrolled 382 CRC patients. The LAR was determined as the serum LDH(U/l) to ALB(g/l) ratio. We compared the levels of LAR and IIBs in different TNM stages and tumor differentiation. The relationship between LAR and IIBs and overall survival (OS) of CRC was determined by Cox regression models. A prognostic nomogram was created using the results of the multivariate analysis and the effectiveness of the nomogram was assessed using the ROC, calibration, and decision curves. We evaluated the relationship between LAR and IIBs and clinical features of CRC. Results The levels of LAR, SII, NLR and PLR in TNM IV stage group (LAR:5.92 (5.23–8.24); SII: 1040.02 (499.51–1683.54); NLR: 2.87 (2.07–5.3); PLR:187.08 (125.31–276.63)) were significantly higher than those in other groups. LAR and NLR showed no significant difference in different tumor differentiation groups, while SII and PLR in undifferentiated groups (SII:543.72 (372.63–1110.20); PLR: 147.06 (106.04–203.92)) were significantly higher than those in well and moderate groups (SII: 474.29 (323.75–716.01); PLR: 126.28 (104.31–167.88)). LAR (HR = 1.317, 95% CI = 1.019–1.454), TNM stage (HR = 2.895, 95% CI = 1.838–4.559), age (HR = 1.766, 95% CI = 1.069–2.922) and lymphocytes (HR = 0.663, 95% CI = 0.456–0.963) were predictors of OS. IIBs, including SII, NLR, and PLR are independent of OS. The LAR-based nomogram AUCs of 1-year, 3-year and 5-year survival probabilities in the training cohort were 0.86, 0.72, and 0.71, respectively, and the AUCs of the validation cohort were 0.85, 0.71, and 0.69 respectively. The LAR-based nomogram's ROC curves and calibration curves demonstrated higher OS discriminative performance. The decision curves demonstrated greater net benefit in the survival prediction. Conclusion Preoperative LAR is a potential prognostic marker in CRC patients, while SII, NLR, and PLR are independent of OS. LAR was associated with tumor stage in CRC patients, but not with tumor differentiation.

Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer.

Novel Blood-Based, Five-Gene Biomarker Set For The Detection Of Colorectal Cancer

Red Cell Distribution Width-a Potential Prognostic Indicator for Colorectal Cancer Patients after Radical Resection in China.

Value Research of NLR, PLR, and RDW in Prognostic Assessment of Patients with Colorectal Cancer

Correlation between peripheral blood hemoglobin/erythrocyte distribution width ratio and prognosis of patients with primary colorectal cancer

The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer

Application Value of Combined Detection of NLR, PNI, D-Dimer, CD3+ T Lymphocytes, and CEA in Colorectal Cancer Screening

Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer

Plasma Extracellular Vesicle Long RNAs Have Potential as Biomarkers in Early Detection of Colorectal Cancer

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer

Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer

Combination of Preoperative NLR, PLR and CEA Could Increase the Diagnostic Efficacy for I-III Stage CRC

Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls

Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types

Expression and Predictive Value of Serum NLR, PLR Combined with SAA in Patients with Different Stages of Colorectal Cancer

An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis

The Prognostic Value of Preoperative Nlr, D-Nlr, Plr and Lmr for Predicting Clinical Outcome in Surgical Colorectal Cancer Patients

The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis

Reproducibility of Lymphocyte-To-Monocyte Ratio (LMR), Neutrophil-To-Lymphocyte Ratio (NLR) and Platelet-To-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer

The value of lactate dehydrogenase to albumin ratio and immune inflammation biomarkers in colorectal cancer

Red blood cell distribution width-to-albumin ratio is associated with all-cause mortality in cancer patients